Detection and genotyping of human papillomavirus by real-time PCR assay

Journal of Clinical Virology

Volumn 56, Issue 3, 2013, Pages 328-333

  Moreau, Frédérique ^a,b   Fetouchi, Rachid ^a   Micalessi, Isabelle ^c   Brejeon, Valérie ^a   Bacon, Nathalie ^a   Jannes, Geert ^d   Le Pendeven, Catherine ^a   Lekbaby, Bouchra ^b   Kremsdorf, Dina ^b   Lacau Saint Guily, Jean ^a   Soussan, Patrick ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b INSERM   (France)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d INNOGENETICS   (Belgium)

Author keywords

Diagnosis; Genotype; HPV; Real time PCR

Indexed keywords

VIRUS DNA;

ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; GENE IDENTIFICATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN TISSUE; HYBRIDIZATION; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SKIN BIOPSY; VIRAL GENETICS; VIRUS LOAD; WART VIRUS;

EID: 84872847659     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2012.11.003     Document Type: Article

References (20)

1. Chaturvedi A.K., Engels E.A., Anderson W.F., Gillison M.L. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008, 26:612-619.
2. Chaturvedi A.K., Engels E.A., Pfeiffer R.M., Hernandez B.Y., Xiao W., Kim E., et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011, 29:4294-4301.
3. Gravitt P.E. The known unknowns of HPV natural history. J Clin Invest 2011, 121:4593-4599.
4. Dufour X., Beby-Defaux A., Agius G., Lacau St Guily J. HPV and head and neck cancer. Eur Ann Otorhinolaryngol Head Neck Dis 2012, 129:26-31.
5. St Guily J.L., Jacquard A.C., Pretet J.L., Haesebaert J., Beby-Defaux A., Clavel C., et al. Human papillomavirus genotype distribution in oropharynx and oral cavity cancer in France - the EDiTH VI study. J Clin Virol 2011, 51:100-104.
6. Cuzick J., Arbyn M., Sankaranarayanan R., Tsu V., Ronco G., Mayrand M.H., et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 2008, 26(Suppl. 10):K29-K41.
7. Borget I., Abramowitz L., Mathevet P. Economic burden of HPV-related cancers in France. Vaccine 2011, 29:5245-5249.
8. Kleter B., van Doorn L.J., Schrauwen L., Molijn A., Sastrowijoto S., ter Schegget J., et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999, 37:2508-2517.
9. Kleter B., van Doorn L.J., ter Schegget J., Schrauwen L., van Krimpen K., Burger M., et al. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 1998, 153:1731-1739.
10. Galan-Sanchez F., Hernandez-Menendez M., De Los Rios Hernandez M.A., Rodriguez-Iglesias M. Performance of the New INNO-LiPA HPV extra to genotype human papillomavirus in cervical cell specimens. Acta Cytol 2011, 55:341-343.
11. Galan-Sanchez F., Rodriguez-Iglesias M.A. Comparison of human papillomavirus genotyping using commercial assays based on PCR and reverse hybridization methods. APMIS 2009, 117:708-715.
12. Steinau M., Onyekwuluje J.M., Scarbrough M.Z., Unger E.R., Dillner J., Zhou T. Performance of commercial reverse line blot assays for human papillomavirus genotyping. J Clin Microbiol 2012, 50:1539-1544.
13. Micalessi I.M., Boulet G.A., Bogers J.J., Benoy I.H., Depuydt C.E. High-throughput detection, genotyping and quantification of the human papillomavirus using real-time PCR. Clin Chem Lab Med 2012, 50:655-661.
14. Forslund O., Antonsson A., Nordin P., Stenquist B., Hansson B.G. A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin. J Gen Virol 1999, 80(Pt 9):2437-2443.
15. Payan C., Ducancelle A., Aboubaker M.H., Caer J., Tapia M., Chauvin A., et al. Human papillomavirus quantification in urine and cervical samples by using the Mx4000 and LightCycler general real-time PCR systems. J Clin Microbiol 2007, 45:897-901.
16. Zur Hausen H. Papillomaviruses in the causation of human cancers - a brief historical account. Virology 2009, 384:260-265.
17. Lutringer-Magnin D., Kalecinski J., Barone G., Leocmach Y., Regnier V., Jacquard A.C., et al. Human papillomavirus (HPV) vaccination: perception and practice among French general practitioners in the year since licensing. Vaccine 2011, 29:5322-5328.
18. Garcini L.M., Galvan T., Barnack-Tavlaris J.L. The study of human papillomavirus (HPV) vaccine uptake from a parental perspective: a systematic review of observational studies in the United States. Vaccine 2012, 30:4588-4595.
19. Tracy L., Gaff H.D., Burgess C., Sow S., Gravitt P.E., Tracy J.K. Estimating the impact of human papillomavirus (HPV) vaccination on HPV prevalence and cervical cancer incidence in Mali. Clin Infect Dis 2011, 52:641-645.
20. Ribassin-Majed L., Lounes R., Clemencon S. Efficacy of vaccination against HPV infections to prevent cervical cancer in France: present assessment and pathways to improve vaccination policies. PLoS ONE 2012, 7:e32251.